Florbetaben (18F)

氟比他班 F18

Report date: 2026/04/29 20:02:18

Base Information

Drug NameFlorbetaben (18F)
Drug Alias Name氟[18F]贝他苯Florbetabenum (18F)[18F]Florbetaben氟贝他苯[18F]氟比他班 +[17] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18F +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsContrast agentsHyponatremiaAmyloidosis +[10] 
Global Approved IndicationsContrast agentsHyponatremiaAlzheimer Disease
Approved Indications in ChinaContrast agentsAlzheimer Disease
Original Approved Country/TerritoryEU
Original Approved Date2014/02/20
Country/TerritoryUnited StatesAustraliaGermany +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAvid Radiopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPiramal ImagingLantheusPiramal Healthcare Ltd +[6] 
Inactive CompaniesTianjin Atom High Science Isotopes Medicine Co LtdStanford UniversityMolecular Neuroimaging Llc +[5] 
Active IndicationsContrast agentsHyponatremiaAmyloidosis +[5] 
Inactive IndicationsDown SyndromeDementiaSupranuclear Palsy, Progressive +[5] 

Other Information

ATC CodeV09AX06
Related LinksWikipediaDrugBankKEGG